FI970331A0 - The drug administration composition for nasal administration - Google Patents

The drug administration composition for nasal administration

Info

Publication number: FI970331A0
Authority: FI; Finland
Prior art keywords: administration; composition; nasal; drug; drug administration
Prior art date: 1994-07-26

Application number

FI970331A

Other languages

Finnish (fi)

Swedish (sv)

Other versions

FI970331L (en

Inventor

Peter Watts

Lisbeth Illum

Original Assignee

Danbiosyst Uk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-26

Filing date

1997-01-27

Publication date

1997-01-27

1997-01-27 Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk

1997-01-27 Publication of FI970331L publication Critical patent/FI970331L/en

1997-01-27 Publication of FI970331A0 publication Critical patent/FI970331A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Otolaryngology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Cell Biology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)

FI970331A 1994-07-26 1997-01-27 The drug administration composition for nasal administration FI970331A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9414966A GB9414966D0 (en)	1994-07-26	1994-07-26	Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en)	1994-07-26	1995-07-24	Drug delivery composition for the nasal administration of antiviral agents

Publications (2)

Publication Number	Publication Date
FI970331L FI970331L (en)	1997-01-27
FI970331A0 true FI970331A0 (en)	1997-01-27

Family

ID=10758832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI970331A FI970331A0 (en)	1994-07-26	1997-01-27	The drug administration composition for nasal administration

Country Status (7)

Country	Link
EP (1)	EP0773791A1 (en)
JP (1)	JPH10506376A (en)
CA (1)	CA2195639A1 (en)
FI (1)	FI970331A0 (en)
GB (2)	GB9414966D0 (en)
NO (1)	NO970252D0 (en)
WO (1)	WO1996003142A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0362531B1 (en)	1988-09-01	1999-11-10	Bayer Corporation	A human rhinovirus receptor protein that inhibits virus infectivity
US5879712A (en) *	1995-06-07	1999-03-09	Sri International	Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
WO1997032596A1 (en) *	1996-03-06	1997-09-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Intercellular adhesion molecule powder formulation
GB9700624D0 (en)	1997-01-14	1997-03-05	Danbiosyst Uk	Drug delivery composition
GB9707934D0 (en) *	1997-04-18	1997-06-04	Danbiosyst Uk	Improved delivery of drugs to mucosal surfaces
US6391452B1 (en)	1997-07-18	2002-05-21	Bayer Corporation	Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
EP0994700A4 (en) *	1997-07-18	2000-10-18	Bayer Ag	METHODS FOR REMOVING RESIDUAL SOLVENT FROM NASAL MEDICINAL COMPOSITIONS
JP2004500305A (en) *	1997-10-31	2004-01-08	フアルマシア・コーポレーシヨン	Sustained-release composition containing gellan gum gel
ES2249846T3 (en) *	1997-12-02	2006-04-01	Archimedes Development Limited	COMPOSITIONS FOR NASAL ADMINISTRATION.
GB0015682D0 (en) *	2000-06-28	2000-08-16	Bristol Myers Squibb Co	Sprayable wound care composition
GB2378383A (en) *	2001-06-06	2003-02-12	Gursharan Moonga	Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en)	2003-01-10	2003-02-12	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
GB0328186D0 (en)	2003-12-05	2004-01-07	West Pharm Serv Drug Res Ltd	Intranasal compositions
GB0403938D0 (en) *	2004-02-21	2004-03-24	West Pharm Serv Drug Res Ltd	Chitosan containing solution
WO2008091588A1 (en)	2007-01-22	2008-07-31	Targacept, Inc.	Intranasal, buccal, and sublingual administration of metanicotine analogs
DE102008007759B4 (en)	2007-12-04	2009-09-24	Atlantichem Gmbh	Agent for preventing discoloration when washing textiles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4946870A (en) *	1986-06-06	1990-08-07	Union Carbide Chemicals And Plastics Company Inc.	Delivery systems for pharmaceutical or therapeutic actives
ATE114972T1 (en) *	1987-11-02	1994-12-15	Baylor College Medicine	USE OF ICAM-1 OR ITS FUNCTIONAL DERIVATIVES TO TREAT NON-SPECIFIC INFLAMMATION.
EP0362531B1 (en) *	1988-09-01	1999-11-10	Bayer Corporation	A human rhinovirus receptor protein that inhibits virus infectivity
SE8804164A0 (en) *	1988-11-17	1990-05-18	Per Prisell	Pharmaceutical preparation
GB2237510B (en) *	1989-11-04	1993-09-15	Danbiosyst Uk	Small particle drug compositions for nasal administration
AU2763692A (en) *	1991-10-02	1993-05-03	Boehringer Ingelheim Pharmaceuticals, Inc.	Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
HUT75827A (en) *	1992-06-22	1997-05-28	Bayer Ag	Multimeric forms of human rhinovirus receptor protein
GB9310412D0 (en) *	1993-05-20	1993-07-07	Danbiosyst Uk	Nasal nicotine system

1994
- 1994-07-26 GB GB9414966A patent/GB9414966D0/en active Pending
1995
- 1995-07-24 EP EP95925947A patent/EP0773791A1/en not_active Withdrawn
- 1995-07-24 JP JP8505576A patent/JPH10506376A/en active Pending
- 1995-07-24 CA CA002195639A patent/CA2195639A1/en not_active Abandoned
- 1995-07-24 GB GB9700817A patent/GB2305606B/en not_active Expired - Fee Related
- 1995-07-24 WO PCT/GB1995/001735 patent/WO1996003142A1/en not_active Application Discontinuation
1997
- 1997-01-21 NO NO970252A patent/NO970252D0/en not_active Application Discontinuation
- 1997-01-27 FI FI970331A patent/FI970331A0/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU707462B2 (en)	1999-07-08
GB2305606A (en)	1997-04-16
GB9414966D0 (en)	1994-09-14
FI970331L (en)	1997-01-27
JPH10506376A (en)	1998-06-23
NO970252L (en)	1997-01-21
EP0773791A1 (en)	1997-05-21
GB9700817D0 (en)	1997-03-05
AU2988695A (en)	1996-02-22
WO1996003142A1 (en)	1996-02-08
NO970252D0 (en)	1997-01-21
GB2305606B (en)	1998-08-05
CA2195639A1 (en)	1996-02-08

Publication	Publication Date	Title
MX9101175A (en)	1992-05-04	PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
FI955583L (en)	1996-01-19	Nasal drug delivery composition containing nicotine
DK1035833T3 (en)	2006-01-09	Composition for nasal administration
IT1284049B1 (en)	1998-05-08	NASAL ADMINISTRATION DRESSING
DE69302933D1 (en)	1996-07-11	Drug delivery system
DE69133445D1 (en)	2005-03-17	Drug delivery system
DE69821457D1 (en)	2004-03-11	Controlled drug delivery compositions
DE69531788D1 (en)	2003-10-23	IMPROVED BIOADHESIVE PHARMACEUTICAL DELIVERY SYSTEM
NO963990D0 (en)	1996-09-23	Two-component device for drug delivery
DE69923076D1 (en)	2005-02-10	TRANSTHORACOAL MEDICAMENT DELIVERY
DE69313510D1 (en)	1997-10-09	Delivery catheter
NO994837L (en)	1999-11-10	Intravesical drug delivery system
DE69224941D1 (en)	1998-05-07	Drug delivery catheter
FI971279A0 (en)	1997-03-26	Drug
KR950700754A (en)	1995-02-20	New drugs (NOVEL MEDICAMENT)
NO20004196D0 (en)	2000-08-22	Drug delivery devices
FI944123L (en)	1994-09-08	Pharmaceutical inhalation compositions
DE69810189D1 (en)	2003-01-30	Controlled drug delivery compositions
FI970331A0 (en)	1997-01-27	The drug administration composition for nasal administration
IT8722647A0 (en)	1987-11-13	PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
KR950032276U (en)	1995-12-14	Skin scratch formation for drug administration
SE9400370L (en)	1995-08-05	Therapeutic composition for inhalation
IT8819541A0 (en)	1988-02-25	PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
SE9402845D0 (en)	1994-08-26	Medication delivery device
FI970053A0 (en)	1997-01-07	Transdermal drug delivery system

Legal Events

Date	Code	Title	Description
2006-01-31	MA	Patent expired